Subscribe to our newsletter!

MD-THORACIC ITALIA 10FL INI2ML
Availability In stock
Special Price €83.44 -13% Regular Price €96.00
The price was: €78.69
Discover the product
Description MD-THORACIC ITALIA 10FL INI2ML
MD-THORACIC
Description
Medical device useful for improving mobility; of the thoracic vertebrae, whose primary therapeutic treatment is consisting of the following functions:
1. Barrier effect.
2. Activities; lubricant.
3. Mechanical support in case of pharmacological therapy in progress.
We recommend the use of MD-THORACIC by qualified health personnel, in private or public health structures to:
- improve the mobility of the thoracic tract of the spinal column;
- to promote muscle relaxation;
- to support the muscular structures in disorders caused by postural defects;
- to relieve localized pain and that caused by movement and postural defects.
Mode À of use
MD-THORACIC pu Ò be used alone or combined with other medical devices belonging to the same line, in order to guarantee a personalized treatment based on the individual clinical picture.
In cases where supportive treatment is required in the event of acute pain, MD- THORACIC can Ò be associated with MD-NEURAL, MD-POLY and MD-MUSCLE (one or more of these).
Furthermore, in cases where a supportive therapy to the tissue matrix is required or an action of slowing of physiological aging, MD-THORACIC can Ò be associated with MD-MATRIX and MD-TISSUE.
Therapeutic protocol for the periarticular route : 2 treatments for the first 2 weeks; then 1 treatment until symptoms improve (on average 8-10 sessions).
For chronic diseases: continue with 1 treatment per week for one month until symptoms improve, and then with 1 treatment per month.
The area of application must be aseptic; introduce the needle nearby of the joints to a depth; of 2-4 mm.
For this use of the medical device we recommend the use of the following materials and accessories:
& bull; Material to ensure skin asepsis: disposable glove, iodine-based solution, alcoholic solution, sterile gauze, ethyl chloride-based skin spray.
& bull; Needles: sterile 27 G.
& bull; Syringes: 5 or 10 cc, according to the quantity; of solution to inject.
Components
Collagen of porcine origin.
Excipients: Black cohosh, NaCl, injectable water.
Warnings < / b>
Disposable.
It is not; no cases of hypersensitivity have been reported to MD-THORACIC.
Contains collagen of animal origin of porcine species. Patients with known hypersensitivity the component or excipients must be previously subjected to injective testing in the arm and kept under observation for one hour. Back pain requires differential diagnosis with pain secondary to primary or metastatic tumors; reflex and referred pain of visceral departure. A slight redness in the area of the injection may be; be due to the mechanical effect of the needle or a skin reaction.
Application may cause burning / painful symptoms at the injection sites, which generally resolve within 5-10 minutes after the end of treatment.
È skin cleansing / disinfection required before and after application.
Any pyogenic bacteria may produce abscess in the injection area.
Keep out of the reach and sight of children.
Do not use after expiration.
Use the product immediately after opening.
Do not use if the seal is broken or tampered with.
After opening, the contents of the vial must be injected immediately.
Do not use in in case of damage to the packaging.
Storage
Store at a temperature of 2 & deg; C and 30 & deg; C, protect from sunlight and frost.
The date of expiry date refers to the product in unopened package, correctly stored.
Format
Box of 10 sterile 2 ml vials.
Cod. < / b> MD12
Medical device useful for improving mobility; of the thoracic vertebrae, whose primary therapeutic treatment is consisting of the following functions:
1. Barrier effect.
2. Activities; lubricant.
3. Mechanical support in case of pharmacological therapy in progress.
We recommend the use of MD-THORACIC by qualified health personnel, in private or public health structures to:
- improve the mobility of the thoracic tract of the spinal column;
- to promote muscle relaxation;
- to support the muscular structures in disorders caused by postural defects;
- to relieve localized pain and that caused by movement and postural defects.
Mode À of use
MD-THORACIC pu Ò be used alone or combined with other medical devices belonging to the same line, in order to guarantee a personalized treatment based on the individual clinical picture.
In cases where supportive treatment is required in the event of acute pain, MD- THORACIC can Ò be associated with MD-NEURAL, MD-POLY and MD-MUSCLE (one or more of these).
Furthermore, in cases where a supportive therapy to the tissue matrix is required or an action of slowing of physiological aging, MD-THORACIC can Ò be associated with MD-MATRIX and MD-TISSUE.
Therapeutic protocol for the periarticular route : 2 treatments for the first 2 weeks; then 1 treatment until symptoms improve (on average 8-10 sessions).
For chronic diseases: continue with 1 treatment per week for one month until symptoms improve, and then with 1 treatment per month.
The area of application must be aseptic; introduce the needle nearby of the joints to a depth; of 2-4 mm.
For this use of the medical device we recommend the use of the following materials and accessories:
& bull; Material to ensure skin asepsis: disposable glove, iodine-based solution, alcoholic solution, sterile gauze, ethyl chloride-based skin spray.
& bull; Needles: sterile 27 G.
& bull; Syringes: 5 or 10 cc, according to the quantity; of solution to inject.
Components
Collagen of porcine origin.
Excipients: Black cohosh, NaCl, injectable water.
Warnings < / b>
Disposable.
It is not; no cases of hypersensitivity have been reported to MD-THORACIC.
Contains collagen of animal origin of porcine species. Patients with known hypersensitivity the component or excipients must be previously subjected to injective testing in the arm and kept under observation for one hour. Back pain requires differential diagnosis with pain secondary to primary or metastatic tumors; reflex and referred pain of visceral departure. A slight redness in the area of the injection may be; be due to the mechanical effect of the needle or a skin reaction.
Application may cause burning / painful symptoms at the injection sites, which generally resolve within 5-10 minutes after the end of treatment.
È skin cleansing / disinfection required before and after application.
Any pyogenic bacteria may produce abscess in the injection area.
Keep out of the reach and sight of children.
Do not use after expiration.
Use the product immediately after opening.
Do not use if the seal is broken or tampered with.
After opening, the contents of the vial must be injected immediately.
Do not use in in case of damage to the packaging.
Storage
Store at a temperature of 2 & deg; C and 30 & deg; C, protect from sunlight and frost.
The date of expiry date refers to the product in unopened package, correctly stored.
Format
Box of 10 sterile 2 ml vials.
Cod. < / b> MD12